Genetic aspects of cerebrovascular disease

Stroke

Volumn 22, Issue 2, 1991, Pages 276-280

  Alberts, Mark J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBROVASCULAR DISEASE; FEMALE; GENETICS; HUMAN; MALE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

CEREBROVASCULAR DISORDERS; EPIDEMIOLOGIC METHODS; HUMAN; LINKAGE (GENETICS); MOLECULAR BIOLOGY; RISK FACTORS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025970235     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.22.2.276     Document Type: Article

References (45)

1. Lander E: Mapping complex genetic traits in humans, in Davies K (ed): Genome Analysis: A Practical Approach. Oxford, IRL Press, 1988, pp 171-187
2. Payne CS, Roses AD: The molecular genetic revolution: Its impact on clinical neurology. Arch Neurol 1988;45:1366-1375
3. Weeks D, Lange K: The affected-pedigree-member method of linkage analysis. Am J Hum Genet 1988;42:315-326
4. Risch N: Linkage strategies for genetically complex traits: II. The power of affected relative pairs. Am J Hum Genet 1990; 46:229-241
5. Hunt SC, Hasstedt SJ, Kuida H, Stults BM, Hopkins PN, Williams RR: Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins. Am J Epidemiol 1989;129:625-638
6. Grotta J, Yatsu F, Pettigrew L, Rhoades H, Bratina P, Vital D, Alam R, Earls R, Picone C: Prediction of carotid stenosis progression by lipid and hematologic measurements. Neurol-ogy 1989;39:1325-1331
7. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larson B, Welin L, Tibblin G: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501-505
8. Steinberg D: Lipoproteins and the pathogenesis of atherosclerosis. Circulation 1987;76:508-514
9. Seed M, Hoppichler F, Reaveley D, McCarthy S, Thompson G, Boerwinkle E, Unterman G: Relation of serum lipoprotein (a) concentration and apolipoprotein (a) phenotype to coronary heart disease in patients with familial hypercholesterol-emia. N Engl J Med 1990;322:1494-1499
10. Third J, Montag J, Flynn M, Freidel J, Laskarzewski P, Glueck CJ: Primary and familial hypoalphalipoproteinemia. Metabolism 1984;33:136-146
11. Brown M, Goldstein J, Fredrickson D: Familial type 3 hyper-lipoproteinemia, in Stanbury J, Wyngaarden J, Frederickson D (eds): The Metabolic Basis of Inherited Disease. New York, McGraw-Hill, 1983, pp 655-671
12. Natowicz M, Kelley RI: Mendelian etiologies of stroke. Ann Neurol 1987;22:175-192
13. Alter M: Genetic factors in cerebrovascular accidents. Trans Am Neurol Assoc 1967;92:205-208
14. Alter M, Kluznik J: Genetics of cerebrovascular accidents. Stroke 1972;3:41-48
15. Gifford AJ: An epidemiological study of cerebrovascular disease. Am J Public Health 1966;6:452-461
16. Herman B, Schmitz PI, Leyten AC, Van LJH, Frenken CW, Op de Coul AAW, Schulte BP: Multivariate logistic analysis of risk factors for stroke in Tilburg, The Netherlands. Am J Epidemiol 1983;118:514-525
17. Heyden S, Heyman A, Camplong L: Mortality patterns among parents of patients with atherosclerotic cerebrovascular disease. J Chronic Dis 1969;22:105-110
18. Khaw KT, Barrett CE: Family history of stroke as an independent predictor of ischemic heart disease in men and stroke in women. Am J Epidemiol 1986; 123:59-66
19. Marshall J: Familial incidence of cerebrovascular disease. J Med Genet 1971;8:84-89
20. Marshall J: Familial incidence of cerebral hemorrhage. Stroke 1973;4:38-41
21. Welin L, Svardsudd K, Wilhelmsen L, Larsson B, Tibblin G: Analysis of risk factors for a stroke cohort of men born in 1913. N Engl J Med 1987;317:521-526
22. Howard G, Evans G, Toole JF, Tell J, Rose L, Espeland M, Truscott B: Characteristics of stroke victims associated with early cardiovascular mortality in their children. J Clin Epidemiol 1990;43:49-54
23. Diaz JF, Hachinski VC, Pederson LL, Donald A: Aggregation of multiple risk factors for stroke in siblings of patients with brain infarction and transient ischemic attacks. Stroke 1986; 17:1239-1242
24. Kagan A, Popper JS, Rhoads GG: Factors related to stroke incidence in Hawaii Japanese men: The Honolulu Heart Study. Stroke 1980;11:14-21
25. Deutscher S, Epstein F, Kjelsberg M: Familial aggregation of coronary heart disease. Circulation 1966;33:911-924
26. Nora J, Lortscher R, Spangler R, Nora A, Kimberling W: Genetic-epidemiological study of early-onset ischemic heart disease. Circulation 1980;61:503-508
27. Berg K: Twin research in coronary heart disease, in Parisi GL, Nance WE (eds): Twin Research 3: Epidemiological and Clinical Studies. New York, Alan R Liss, 1981, pp 117-130
28. de Faire U: Ischaemic heart disease in death discordant twins: A study on 205 male and female pairs. Acta Med Scand Suppl 1974;568:1-109
29. Bousser M-G, Tournier-Lasserve E, Aylward R, Tourbah A, Dormont D, Romero N, Cabanis E: Recurrent strokes in a family with diffuse white matter abnormalities and muscular lipiosis-A new mitochondrial cytopathy? J Neurol 1988; 235(suppl):S4-S5
30. Sonninen V, Savontaus ML: Hereditary multi-infarct dementia. Eur Neural 1987;27:209-215
31. Boyd MC, Steinbok P, Paty DW: Familial arteriovenous malformations: Report of four cases in one family. J Neurosurg 1985;62:597-599
32. Snead O, Acker J, Morawetz R: Familial arteriovenous malformation. Ann Neurol 1979;5:585-587
33. Aberfeld DC, Rao KR: Familial arteriovenous malformation of the brain. Neurology 1981;31:184-186
34. Rigamonti D, Hadley MN, Drayer BP, Johnson PC, Hoenig RK, Knight JT, Spetzler RF: Cerebral cavernous malformations: Incidence and familial occurrence. N Engl J Med 1988; 319:343-347
35. Pettigrew L, Immken L, Hejtmancik J: Natural history of familial cavernous hemangioma (abstract). Stroke 1989;20:139A
36. Lozano AM, Leblanc R: Familial intracranial aneurysms. J Neurosurg 1987;66;522-528
37. Leblanc R, Lozano AM, van der Rest M, Guttmann RD: Absence of collagen deficiency in familial cerebral aneurysms. J Neurosurg 1989;70:837-840
38. Levy E, Lopez OC, Ghiso J, Geltner D, Frangione B: Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases. J Exp Med 1989; 169:1771-1778
39. Palsdottir A, Abrahamson M, Thorsteinsson L, Arnason A, Olafsson I, Grubb A, Jensson O: Mutation in cystatin C gene causes hereditary brain haemorrhage. Lancet 1988;2:603-604
40. Levy E, Carman M, Fernandez-Madrid I, Power M, Lieber-burg I, van Duinen SG, Bots GTAM, Luyendik W, Frangione B: Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990;248: 1124-1126
41. Kitahara T, Okumara K, Semba A, Yamaura A, Makino H: Genetic and immunologic analysis on Moya-Moya. J Neurol Neurosurg Psychiatry 1982;45:1048-1052
42. Wattendorff A, Bots G, Went L, Endtz L: Familial cerebral amyloid angiopathy presenting as recurrent cerebral hemorrhage. J Neurol Sci 1982;55:121-135
43. Munro J: Transient global amnesia-Familial incidence. J Neurol Neurosurg Psychiatry 1982;45:1070
44. Coyle P, Odenheimer DJ, Sing CF: Cerebral infarction after middle cerebral artery occlusion in progenies of spontaneously stroke-prone and normal rats. Stroke 1984;15:711-716
45. Yamori Y: Importance of genetic factors in stroke: An evidence obtained by selective breeding of stroke-prone and -resistant SHR. Jpn Circ J 1974;38:1095-1100